Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (1420)	3/1/2000 11:10:00 PM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 2001

The following puts clinical trials for ADCON-P into a very human perspective. Best regards John de C > Forum: alt.infertility.pregnancy >> Thread: Scar tissue drug for female surgery >> Message 5 of 71 Subject:Scar tissue drug for female surgery Date: 02/17/2000 Author: carmella2520 <carmella2520@my-deja.com> I am planning to have surgery to unblock one of my fallopian tubes, which my fertility specialist recommends. He is proposing to use Adcon- P (by Gliatech, Inc. of Cleveland, Ohio) to pour in my abdominal cavity over the tubes prior to completing the procedure in order to reduce formation of scar tissue/adhesions and make them easier to remove. He says it has been used successfully for other types of surgeries and in other countries. In order to use the liquid, he needs me to sign a consent form requiring me to have a mandatory second surgery, primarily to check my results for the study and remove any adhesions that may have formed. I?m concerned about both using the experimental liquid and undergoing general anesthesia again for a second surgery that may not be necessary. Any help, thoughts or ideas appreciated. Thanks.